openPR Logo
Press release

Aneurysmal Subarachnoid Hemorrhage Market Prospective Growth 2025 - Arbor Pharmaceuticals

07-11-2018 11:42 AM CET | Health & Medicine

Press release from: TMR Research

Aneurysmal Subarachnoid Hemorrhage Market Prospective Growth

Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot

According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the U.S. wherein 30,000 people are diagnosed for SAH each year. Among these cases, raptured cerebral aneurysms accounts for nearly 80% of the non-traumatic aneurysmal subarachnoid hemorrhage. Going forward, these numbers are expected to mount even further, and thereby prove to be boon for the players in the global market for aneurysmal subarachnoid hemorrhage.

Smoking, hypertension, history of intracranial aneurysms in immediate relatives, chronic alcohol use are some of the common causes of aneurysmal subarachnoid hemorrhage, while the symptoms include headache, facial or orbital pain, unilateral third nerve palsy, bilateral lower extremity weakness, and vision loss. With no absolute therapy available and severity of the implications, early detection of SAH is of utmost importance and hence, there are vast opportunities available for the players venturing in the aneurysmal subarachnoid hemorrhage market. In addition to that, the NIH study reveals that aneurysmal subarachnoid hemorrhage is more prevalent in developed region of North America including the U.S. in comparison to Japan and China in Asia Pacific. With the presence of several key players in the healthcare sector in North America, the research and development pertaining to aneurysmal subarachnoid hemorrhage is expected to drive the global market for the same.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=31

Global Aneurysmal Subarachnoid Hemorrhage Market: Overview

Aneurismal subarachnoid hemorrhage is a type of stroke and accounts for almost 7% of all strokes. It is listed under medical emergency conditions and can cause severe disability or can be fatal as well. Subarachnoid hemorrhage is sudden bleeding into the subarachnoid space of the central nervous system that may occur due to head injury, rupture of cerebral aneurysm, and aneurysm in other blood vessels. The most significant cause of aneurysmal subarachnoid hemorrhage is trauma. Some other causes of this condition are migraine, intra-cerebral hemorrhage, meningitis, and cerebral venous sinus thrombosis. In addition, lifestyle factors, smoking, genetics, hypertension, and excessive alcohol consumption are also significant factors for subarachnoid hemorrhage.

The report is an all-important tool to understand the progression of the global aneurysm subarachnoid hemorrhage market between 2017 and 2025. In this report, the various market forces and growth indicators are analyzed at length to present a clear picture of strengths, weakness, threats, and opportunities of the market until the end of the forecast period in 2025.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=31

Global Aneurysmal Subarachnoid Hemorrhage Market: Market Segmentation

The global aneurysmal subarachnoid hemorrhage market is segmented on the basis of diagnostic test, therapy, and geography. By diagnostic test, CT scan and MRI are the components of this market. Lumber puncture is mandatory in cases where imaging shows indefinite results. Xanthochromia is another diagnostic test that helps in the detection of aneurysmal subarachnoid hemorrhage. Cerebral angiography and transcranial Doppler ultrasound are also used for detecting aneurysmal subarachnoid hemorrhage.

The regional segments of the global aneurysm subarachnoid hemorrhage market are North America, Asia Pacific, Europe, and Rest of the World. As per an article published by Elsevier in 2014, countries such as Japan and Finland have high incidence rates of aneurysmal subarachnoid hemorrhage.

Global Aneurysmal Subarachnoid Hemorrhage Market: Drug Acceptance

In May 2013, Arbor Pharmaceuticals received FDA approval for Nymalize containing nimodipine for patients with subarachnoid hemorrhage. Currently, Arbor Pharmaceuticals possess the commercial rights of Nymalize solely in the US.

Read Comprehensive Overview of Report @ https://www.tmrresearch.com/aneurysmal-subarachnoid-hemorrhage-market

The primary treatment for aneurysmal subarachnoid hemorrhage involves stabilizing the patient by repairing the cause of bleeding with the help of vasospasms such as calcium channel blockers such as nimodipine. Anti-anxiety medications and pain killers, when administered, helps relieve headaches and pressure in the skull. Phenyton is used to treat or prevent the occurrence of seizures.

The treatment also focuses on alleviating symptoms and preventing complications such as permanent brain damage. Surgery is advised in cases where removal of large volume of blood is required to alleviate pressure on the brain. Aneurysm clipping, endovascular coiling, and craniotomy are some of the surgical procedures carried out for aneurysmal subarachnoid hemorrhage. Endovascular coiling involves placing coils in the aneurysm and stents in the blood vessel in order to lessen risk of further bleeding.

Companies and Institutions Mentioned in the Report

Some of the leading companies in the global aneurysmal subarachnoid market are Arbor Pharmaceuticals, Edge Therapeutics Inc., and Actelion Ltd. Key institutions that contribute to the global aneurysmal subarachnoid hemorrhage market are Chinese University of Hong Kong, Utrecht University, University of Miami, University of Cambridge, and the University of Calgary among others.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aneurysmal Subarachnoid Hemorrhage Market Prospective Growth 2025 - Arbor Pharmaceuticals here

News-ID: 1119969 • Views: 219

More Releases from TMR Research

Smart Factory Market Analysis of Key Players, End User, Demand and Consumption B …
Global Smart Factory Market: Overview The global smart factory sector has been propelled by the need for efficient and precise ways of operating a manufacturing unit. The increasing adoption of industrial robots in the global manufacturing sector was the first step for the smart factory market. Modern factories incorporate sophisticated industrial robotic systems, Internet of Things technology, and machine communication technology to enable smooth automated manufacturing. The rising government support to
Terrestrial Trunked Radio (TETRA) Market Analysis by Growth, Size (Value and Vol …
Terrestrial Trunked Radio (TETRA) Market: Overview The rising demand for higher level of encryption for voice to meet the security needs for public safety organizations is boosting the global terrestrial trunked radio (TETRA) market. The ability of terrestrial trunked radios to transfer data quickly as compared to the mobile communications earlier is also boosting their demand. Terrestrial trunked radio is a private, digital mobile radiotechnology, finding its application in medical, transport,
Timing Devices Market Growth and Restrain Factors Analysis 2017 – 2025
Global Timing Devices Market: Overview The three broad segments of timing devices are semiconductor clocks, oscillators, and resonators. Timing devices are the semiconductor components bringing about timely performance of electronic products. Small timing devices are usually pocket instruments and wrist instruments and the larger ones are typically table and the panel-mounted units, which includes demonstrational timers. Timing devices run on electricity and have a digital display. Akin to clocks and the watches,
Earphones and Headphones Market Latest Report with Forecast to 2025
Global Earphones and Headphones Market: Overview Headphones are a pair of two simple speakers attached to a band that goes across the wearer’s head in such a manner that the speakers are positioned over the ears. This delivers a personal, immersive listening experience directly into the ears. The use of headphones is somewhat unique over traditional speakers as the latter vibrate large segments of air within a room to recreate

All 5 Releases


More Releases for Subarachnoid

Aneurysmal Subarachnoid Hemorrhage Market Preventing challenges complications 20 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Top Factors Driving the Global Aneurysmal Subarachnoid Hemorrhage Drugs Market
HTF MI recently introduced Global Aneurysmal Subarachnoid Hemorrhage Drugs Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. At present, the market is developing its presence and some of the key players from the complete study are Arbor Pharmaceuticals Inc. (US), Edge Therapeutics, Inc. (US), Johnson & Johnson (Actelion Pharmaceuticals Ltd.) (US), Mylan N.V. (US), Orexo AB (Sweden), Pfizer
Aneurysmal Subarachnoid Hemorrhage Market witness lethargic growth 2025
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market Dynamic Business Environment during 20 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market - Predicted Analysis and Forecast 2017 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market - Segmentation Of Industry & Forecast …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the